Conventional Chemotherapy and Oncogenic Pathway Targeting in Ovarian Carcinosarcoma Using a Patient-Derived Tumorgraft

Ovarian carcinosarcoma is a rare subtype of ovarian cancer with poor clinical outcomes. The low incidence of this disease makes accrual to large clinical trials challenging. However, studies have shown that treatment responses in patient-derived xenograft (PDX) models correlate with matched-patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Glaser, Gretchen, Weroha, S. John, Becker, Marc A., Hou, Xiaonan, Enderica-Gonzalez, Sergio, Harrington, Sean C., Haluska, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427104/
https://www.ncbi.nlm.nih.gov/pubmed/25962155
http://dx.doi.org/10.1371/journal.pone.0126867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427104/
https://www.ncbi.nlm.nih.gov/pubmed/25962155
http://dx.doi.org/10.1371/journal.pone.0126867

Ejemplares similares